Binding Site Descriptor Embedding for Novel Ligand Generation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing deep generative learning models struggle to effectively generate coherent molecular structures that are not present in a given training dataset, particularly in the context of chemical compounds, and fail to efficiently integrate spatial and textual representations of protein-ligand interactions.

Innovation Solution

A neural network architecture with a bottleneck structure, such as a U-net, is employed to create an engineered chemical space that unifies embeddings for protein and ligand descriptors, using contrastive learning and reconstruction losses to ensure similarity between targetable pairs while maintaining dissimilarity in non-targetable pairs, enabling the generation of novel molecular structures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If existing deep generative learning models are used to generate molecular structures, then molecular structure generation is attempted, but the models fail to generate coherent molecular structures that are not present in the training dataset

Engineering Contradiction:
Improveability to generate novel molecular structuresVSAvoidcoherence of generated molecular structures
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent merges spatial representations (3D protein pocket geometry) and textual representations (molecular descriptors) into a unified embedding space. This integration allows the model to simultaneously consider both the spatial constraints of the binding site and the chemical properties of ligands, enabling generation of novel yet coherent molecular structures that satisfy both geometric and chemical requirements.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent introduces contrastive learning as an intermediary mechanism that learns to distinguish between targetable and non-targetable ligand-target pairs. This intermediary contrastive descriptor space acts as a bridge that guides the generative model to produce molecules with desired binding properties while maintaining structural coherence, resolving the contradiction between novelty and reliability.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If spatial and textual representations of protein-ligand interactions are integrated, then prediction accuracy is improved, but the complexity of the model increases

Engineering Contradiction:
Improveprediction accuracy of ligand-target interactionsVSAvoidmodel architecture complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs a unified embedding space that serves multiple functions simultaneously: it encodes spatial information from protein pocket geometry, incorporates textual molecular descriptors, and provides a common framework for contrastive learning and molecular generation. This multi-functional approach integrates diverse representations without requiring separate processing pipelines, thereby improving prediction accuracy while controlling model complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Manufacturing precision

If contrastive learning is used to ensure similarity between targetable pairs and dissimilarity in non-targetable pairs, then binding site descriptor accuracy is improved, but training complexity increases

Engineering Contradiction:
Improveaccuracy of binding site descriptorsVSAvoidtraining process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies contrastive learning as a preliminary training step that pre-establishes the unified embedding space and contrastive descriptors before the main molecular generation task. This preliminary action prepares the model with discriminative capabilities, enabling it to accurately distinguish binding-compatible pairs, which simplifies subsequent generation tasks and improves descriptor accuracy without compounding training complexity throughout the entire process.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20260004129A1Structure-based deep generative model for binding site descriptors extraction and de novo molecular generation
Publication Date: 2026.01.01 INSILICO MEDICINE IP LTD
  • US20260004129A1 patent drawing
  • US20260004129A1 patent drawing
  • US20260004129A1 patent drawing

AI summary

In some aspects, the present disclosure describes a method of sampling a ligand. In some embodiments, the method comprises receiving a target descriptor. In some embodiments, the method comprises generating, in an engineered chemical space, a latent descriptor, based at least in part on the target descriptor. In some embodiments, the method comprises generating a ligand descriptor, based at least in part on the latent descriptor.